Showing results (41-50 of 544) with videos related to
Sort By:
Pageof 55
Bone Marrow Transplantation|May 1, 1990
Interferon therapy for Ph1 positive CML patients relapsing after T cell-depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, G Alimena, et al.La Ricerca in Clinica E in Laboratorio|July 1, 1983
Coagulation factor VII. (Biochemistry, role in blood coagulation, methods of assay, congenital deficiencies and relationship with thrombosis)G Mariani, F MandelliRecenti Progressi in Medicina|December 23, 1999
[Treatment of acute and chronic leukemias]F Mandelli, E MontefuscoEuropean Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspectiveP Mazza, S Tura, M Bocchia, et al.Leukemia Research|January 1, 1986
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemiaG Papa, W Arcese, F R Mauro, et al.British Journal of Haematology|September 1, 1984
Acute leukaemia in patients treated for Hodgkin's diseaseG Papa, F R Mauro, A P Anselmo, et al.European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.British Journal of Haematology|March 1, 1996
The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, ItalyF Mandelli, L Annino, B RotoliCurrent Opinion in Oncology|February 1, 1992
Biology and treatment of multiple myelomaF Mandelli, G Avvisati, M TribaltoPageof 55